Dietmar Leitner joins Napp Pharmaceuticals as its new managing director
January 31, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Dietmar Leitner, Napp Pharmaceuticals
Dietmar Leitner has been appointed managing director of Napp Pharmaceuticals, part of the Napp Pharmaceutical Group. Dietmar has worked …
Roche’s Erivedge gains FDA approval
January 31, 2012Sales and Marketing Erivedge, FDA, Roche
The FDA has approved Roche’s Erivedge to treat patients with a common form of skin cancer. Erivedge (vismodegib) is now …
Misinformation charges against Servier dropped
January 30, 2012Sales and Marketing European Commission, Servier, anti-competitive behaviour
The European Commission has dropped a case against Servier in which the French manufacturer was accused of providing misleading information.The …
Pfizer in talks on Sandwich site sale
January 30, 2012Research and Development Pfizer, Sandwich
Pfizer has begun talks with a real estate investor to sell its R&D centre in Sandwich. The site was Pfizer’s …
PM Society celebrates new-look advertising awards
January 30, 2012Medical Communications, Sales and Marketing Creative Lynx, Daaichi Sankyo, PM Society Awards, Torre Lazur McCann
The PM Society has held its annual healthcare advertising awards, which this year saw some significant changes to award categories. …
FDA approves Pfizer cancer drug Inlyta
January 30, 2012Sales and Marketing Nexavar, Pfizer, Sutent, rcc, renal cell carcinoma
Pfizer’s kidney cancer drug Inlyta has gained US approval for second line treatment for the disease. Inlyta (axitinib) is now …
Government bites back against NHS reform naysayers
January 27, 2012Sales and Marketing BMJ, Lansley, NHS, reforms
The UK government has come out against healthcare groups that are opposing its plans to radically reform the NHS. Speaking …
Medical Research Network starts major global expansion programme
January 27, 2012Business Services
Leading unique Clinical Trial Support Organisation (CTSO), Medical Research Network (MRN), has completed the first stage of a major global …
James Murdoch steps down from GSK board
January 27, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, James Murdoch
GlaxoSmithKline has announced that after nine years with the firm, Sir Crispin Davis, Sir Robert Wilson and Larry Culp will …
Boehringer broadens afatinib studies
January 27, 2012Research and Development, Sales and Marketing Boehringer Ingelheim, Cancer, afatinib
Boehringer Ingelheim is expanding the scope of its studies into afatinib to test its use against head and neck cancers. …
Amgen buys Micromet for $1.2 billion
January 27, 2012Research and Development, Sales and Marketing Amgen. Micromet, blinatumomab
Amgen is to buy German biotech firm Micromet for $1.16 billion to broaden its mid-stage pipeline and consolidate its oncology …
AXON Communications appoints Tina Hahn as vice president
January 27, 2012Medical Communications AXON Communications, Tina Hahn
AXON Communications has announced the appointment of Dr Tina Hahn as vice president, based in Copenhagen, Denmark. In addition to …
Bristol-Myers Squibb elects Gerald Storch to board of directors
January 26, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BMS, Gerald Storch
Bristol-Myers Squibb has announced that its board has elected Gerald Storch to serve as a member of the audit committee, …
Abbott strong as it prepares for spin-out
January 26, 2012Sales and Marketing Abbott, GAAP, Humira
Abbott enjoyed a strong 2011 thanks to Humira and emerging market growth, with overall worldwide sales rising by 4.1 per …
Rebif approved for early use in MS
January 26, 2012Sales and Marketing MS, Merck KGaA, Merck Serono, Rebif
The European Commission has approved an indication for multiple sclerosis treatment Rebif that treats early signs of the condition.This EC …
New Leg-Mounted Autoclaves for Designated Clean-rooms
January 26, 2012Manufacturing and Production
Availability of stand-off legs for Priorclave’s range of bench-top autoclaves brings significant advantages to designated CAT 3 application areas providing …
CRAs spend less time on site, more time travelling
January 25, 2012Research and Development CRAs, Clinical Research Associates, Tufts, clinical trials
A new study of how clinical research associates (CRAs) spend their time has produced some interesting and surprising results. The …
Cell-based assays to help speed toxicity studies
January 25, 2012Research and Development Qiagen, cell-based assays, drug discovery
Use of cell-based assay technology is set to grow rapidly over the next decade, helping to speed up drug discovery …
Roche launches $5.7 billion hostile bid for Illumina
January 25, 2012Research and Development, Sales and Marketing Diagnostics, Illumina, Roche
Roche has launched a hostile takeover bid for US diagnostics company Illumina. The Swiss manufacturer appears tired of waiting for …
Premier Research appoints Etienne Drouet as executive director, Oncology Europe
January 25, 2012Business Services, Research and Development, Sales and Marketing Etienne Drouet, Premier Research
Premier Research Group has announced the appointment of Etienne Drouet to the position of executive director, Oncology Europe.In this position, …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
